Literature DB >> 21985362

Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course.

T Hanafusa1, H Azukizawa, S Kitaba, H Murota, N Umegaki, M Terao, S Sano, T Nakagiri, M Okumura, I Katayama.   

Abstract

Thymoma-associated multi-organ autoimmunity is a rare, autoimmune disease that causes colitis, liver dysfunction and cutaneous graft-versus-host (GVH)-like skin damage. This paraneoplastic autoimmune disorder may be due to inadequate T cell selection in the tumour environment of the thymus. Although sporadic case reports have revealed its clinical features, little is known about its pathological mechanism. By comparing the skin-infiltrating T cell subsets with those of GVH disease (GVHD) and other inflammatory skin diseases, we sought to elucidate the pathological mechanism of thymoma-associated multi-organ autoimmunity. Histopathological and immunohistochemical analysis of skin biopsies was performed for three patients with thymoma-associated multi-organ autoimmunity. Histopathological findings of thymoma-associated multi-organ autoimmunity were indistinguishable from those of patients with acute GVHD, although the aetiologies of these diseases are completely different. The frequency of regulatory T cells (T(regs)) is reduced in cutaneous lesions and CD8+ cytotoxic T lymphocytes that massively infiltrate into the epidermis of patients with thymoma-associated multi-organ autoimmunity. Additionally, the ratio of T helper type 17 (Th17) cells to CD4+ cells in patients with thymoma-associated multi-organ autoimmunity and acute GVHD was higher than that in healthy controls, but similar to that in psoriasis vulgaris patients. Similarity of the skin-infiltrating T cell subsets with those of acute GVHD suggested that skin damage in patients with thymoma-associated multi-organ autoimmunity might be induced by self-reactive cytotoxic T lymphocytes under the diminished suppressive capacity of T(regs).
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

Entities:  

Mesh:

Year:  2011        PMID: 21985362      PMCID: PMC3219891          DOI: 10.1111/j.1365-2249.2011.04472.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Central tolerance: learning self-control in the thymus.

Authors:  Kristin A Hogquist; Troy A Baldwin; Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

2.  Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid.

Authors:  Anne Rensing-Ehl; Barbara Gaus; Leena Bruckner-Tuderman; Stefan F Martin
Journal:  Exp Dermatol       Date:  2007-01       Impact factor: 3.960

Review 3.  A central role for central tolerance.

Authors:  Bruno Kyewski; Ludger Klein
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

4.  Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease.

Authors:  Akhil Wadhera; Emanual Maverakis; Nicholas Mitsiades; Primo N Lara; Maxwell A Fung; Peter J Lynch
Journal:  J Am Acad Dermatol       Date:  2007-04-16       Impact factor: 11.527

5.  Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity?

Authors:  G Johan Offerhaus; Marguerite E I Schipper; Audrey J Lazenby; Elizabeth Montgomery; Folkert H M Morsink; Richard J Bende; Alex R Musler; Rene A W van Lier; Carel J M van Noesel
Journal:  Immunol Lett       Date:  2007-09-29       Impact factor: 3.685

6.  Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.

Authors:  Yoshinobu Maeda; Robert B Levy; Pavan Reddy; Chen Liu; Shawn G Clouthier; Takanori Teshima; James L M Ferrara
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

7.  Graft-versus-host-like colitis associated with malignant thymoma.

Authors:  S Kornacki; F C Hansen; A Lazenby
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

Review 8.  FOXP3: of mice and men.

Authors:  Steven F Ziegler
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

9.  Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans.

Authors:  G F Murphy; Y Merot; A K Tong; B Smith; M C Mihm
Journal:  J Invest Dermatol       Date:  1985-03       Impact factor: 8.551

10.  Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.

Authors:  Giovanna Roncador; Philip J Brown; Lorena Maestre; Sophie Hue; Jorge L Martínez-Torrecuadrada; Khoon-Lin Ling; Sarah Pratap; Christy Toms; Bridget C Fox; Vincenzo Cerundolo; Fiona Powrie; Alison H Banham
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

View more
  8 in total

1.  Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma.

Authors:  T Hanafusa; S Matsui; H Murota; M Tani; K Igawa; I Katayama
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

2.  Multimodal immunotherapy ameliorates myasthenia gravis preceded by thymoma-associated multiorgan autoimmunity.

Authors:  Hiroo Kasahara; Kazuki Shimizu; Kouki Makioka; Takaaki Sano; Yoichi Ohtaki; Yoshio Ikeda
Journal:  Immunol Res       Date:  2022-03-14       Impact factor: 2.829

Review 3.  Thymoma-associated multiorgan autoimmunity with exclusive gastrointestinal tract involvement: case report and review of the literature.

Authors:  Tomas Slavik; Fritz M Potgieter; David Brittain
Journal:  Virchows Arch       Date:  2018-01-26       Impact factor: 4.064

4.  Graft-versus-host disease-like erythroderma: a manifestation of thymoma-associated multiorgan autoimmunity.

Authors:  Shay Warren; Kishwer Nehal; Christiane Querfeld; Richard Wong; James Huang; Melissa Pulitzer
Journal:  J Cutan Pathol       Date:  2015-10       Impact factor: 1.587

Review 5.  Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review.

Authors:  Ewa Wrona; Sylwia Dębska-Szmich; Marta Pastuszka; Marcin Braun; Rafał Czyżykowski; Piotr Potemski
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

6.  Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome-From Pemphigus to Lichenoid Dermatitis.

Authors:  Farzan Solimani; Roberto Maglie; Robert Pollmann; Thomas Schmidt; Ansgar Schmidt; Norito Ishii; Björn Tackenberg; Andreas Kirschbaum; Dario Didona; Julia Pickert; Rüdiger Eming; Takashi Hashimoto; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

7.  Graft-versus-host disease-like erythroderma: a sign of recurrent thymoma: A case report.

Authors:  Xiujuan Gui; Xinhai Zhu; Liangjun Guo; Guoqiang Tan; Yan Liu; Yi Tan; Qiufang Chen; Yuwei Song; Shaoqiang Lin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Concurrent renal amyloidosis and thymoma resulting in a fatal ventricular thrombus in a dog.

Authors:  Jennifer M Loewen; Rachel E Cianciolo; Liwen Zhang; Michael Yaeger; Jessica L Ward; Jodi D Smith; Dana N LeVine
Journal:  J Vet Intern Med       Date:  2018-02-27       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.